ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising progress across many clinical and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, far more responsible choice for therapeutic use, partic